Rankings
▼
Calendar
CGEN FY 2021 Earnings — Compugen Ltd. Revenue & Financial Results | Market Cap Arena
CGEN
Compugen Ltd.
$215M
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$6M
+200.0% YoY
Gross Profit
$5M
88.7% margin
Operating Income
-$35M
-584.6% margin
Net Income
-$34M
-570.0% margin
EPS (Diluted)
$-0.41
Cash Flow
Operating Cash Flow
-$23M
Free Cash Flow
-$23M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$132M
Total Liabilities
$25M
Stockholders' Equity
$107M
Cash & Equivalents
$8M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$6M
$2M
+200.0%
Gross Profit
$5M
$2M
+174.2%
Operating Income
-$35M
-$31M
-11.4%
Net Income
-$34M
-$30M
-15.2%
← Q4 2020
All Quarters
Q1 2021 →